Literature DB >> 17083363

Diverse phenotype of Brooke-Spiegler syndrome associated with a nonsense mutation in the CYLD tumor suppressor gene.

Guolong Zhang1, Yijin Huang, Kailin Yan, Wei Li, Xing Fan, Yanhua Liang, Liangdan Sun, Hui Li, Shumei Zhang, Min Gao, Wenhui Du, Sen Yang, Jianjun Liu, Xuejun Zhang.   

Abstract

Brooke-Spiegler syndrome (BSS) is an autosomal dominant disease characterized by cylindromas, trichoepitheliomas and occasionally spiradenomas. The disease gene was mapped to 16q12-13, and mutations in the CYLD gene were identified in families with BSS. In the present report, we describe a large consanguineous Chinese family with BSS showing an intra-family phenotypic variability. Clinically, some affected individuals only revealed discrete small skin-coloured tumors whereas the proband showed an expansion of multiple large tumors on the back of nose and numerous dome-shaped papules on her scalp. Histologically, both trichoepitheliomas and cylindromas were found in the affected individuals. By sequence analysis, we identified a recurrent mutation 2272C>T (R758X) of the CYLD gene in the affected individuals of this family, which was previously identified in other ethnic families with familial cylindromatosis. Our result provided additional information for phenotype-genotype correlation in BSS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17083363     DOI: 10.1111/j.1600-0625.2006.00501.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  9 in total

1.  Cylindroma transforming into basal cell carcinoma in a patient with Brooke-Spiegler syndrome.

Authors:  Justyna Sicinska; Adriana Rakowska; Joanna Czuwara-Ladykowska; Andrzej Mroz; Marcin Lipinski; Anna Nasierowska-Guttmejer; Jolanta Sikorska; Katarzyna Sklinda; Monika Slowinska; Elzbieta Kowalska-Oledzka; Irena Walecka; Jerzy Walecki; Lidia Rudnicka
Journal:  J Dermatol Case Rep       Date:  2007-12-29

2.  Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-κB-dependent manner.

Authors:  Lara Manganaro; Lars Pache; Tobias Herrmann; John Marlett; Young Hwang; Jeffrey Murry; Lisa Miorin; Adrian T Ting; Renate König; Adolfo García-Sastre; Frederic D Bushman; Sumit K Chanda; John A T Young; Ana Fernandez-Sesma; Viviana Simon
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

3.  Epidermal CYLD inactivation sensitizes mice to the development of sebaceous and basaloid skin tumors.

Authors:  Yingai Jane Jin; Sally Wang; Joshua Cho; M Angelica Selim; Tim Wright; George Mosialos; Jennifer Y Zhang
Journal:  JCI Insight       Date:  2016-07-21

Review 4.  Human IRGM gene "to be or not to be".

Authors:  Cemaletin Bekpen; Ramnik J Xavier; Evan E Eichler
Journal:  Semin Immunopathol       Date:  2010-08-25       Impact factor: 9.623

5.  NF-κB and cancer: a paradigm of Yin-Yang.

Authors:  Gutian Xiao; Jing Fu
Journal:  Am J Cancer Res       Date:  2010-12-06       Impact factor: 6.166

Review 6.  Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling.

Authors:  Patrick W Blake; Jorge R Toro
Journal:  Hum Mutat       Date:  2009-07       Impact factor: 4.878

7.  Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis.

Authors:  Ans M W van den Ouweland; Peter Elfferich; Roy Lamping; Raoul van de Graaf; Monique M van Veghel-Plandsoen; S M Franken; A C Houweling
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

8.  The CYLD p.R758X worldwide recurrent nonsense mutation detected in patients with multiple familial trichoepithelioma type 1, Brooke-Spiegler syndrome and familial cylindromatosis represents a mutational hotspot in the gene.

Authors:  Katalin Farkas; Barbara Kocsis Deák; Laura Cubells Sánchez; Ana Mercedes Victoria Martínez; Juan José Vilata Corell; Alfredo Montoro Botella; Goitzane Marcaida Benito; Raquel Rodríguez López; Tomas Vanecek; Dmitry V Kazakov; Joan N R Kromosoeto; Ans M W van den Ouweland; János Varga; Márta Széll; Nikoletta Nagy
Journal:  BMC Genet       Date:  2016-02-09       Impact factor: 2.797

9.  Tumor mapping in 2 large multigenerational families with CYLD mutations: implications for disease management and tumor induction.

Authors:  Neil Rajan; James A A Langtry; Alan Ashworth; Catherine Roberts; Pam Chapman; John Burn; Alison H Trainer
Journal:  Arch Dermatol       Date:  2009-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.